HCA Q2 revenue $18.6B (+6.4%), EPS $6.83 (+23.5%); raises 2025 guidance

HCA Healthcare, Inc.

2025-Q2 EPS reported $13.28 revenue$36,926,000,000

Revenue $18.605B (+6.4% YoY); net income $1.653B (+13.1% YoY).
Diluted EPS $6.83 (+23.5%); adjusted diluted EPS $6.84 (+24.4%).
Adjusted EBITDA $3.849B (+8.4%); same facility admissions +1.8%.
Quarterly cash dividend declared at $0.72/share, payable Sep 30, record Sep 16.
Company announces it is raising full-year 2025 guidance (specific new figures not provided in filing excerpt).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.